DCM Shriram Fine Chemicals Limited (NSE:DSFCL)

Market Cap	2.13B
Revenue (ttm)	4.05B -1.9%
Net Income	47.27M -80.4%
EPS	0.49 -82.4%
Shares Out	86.99M
PE Ratio	50.25
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,167
Average Volume	166,006
Open	23.61
Previous Close	23.36
Day's Range	23.61 - 24.52
52-Week Range	17.28 - 52.50
Beta	n/a
RSI	45.05
Earnings Date	Mar 2, 2026

About NSE:DSFCL

DCM Shriram Fine Chemicals Limited engages in producing, contract manufacturing, and selling of chemicals and their by-products. Its Pharma products includes D (-) alpha phenyl glycine base, D (-) alpha phenyl glycine ethyl potassium dane salt, D (-) alpha phenyl glycine chloride hydrochloride, D (-) para hydroxy phenyl glycine base, D (-) para hydroxy phenyl glycine methyl potassium dane salt, D (-) para hydroxy phenyl glycine methyl ester, DL 2-(2-Chloro Phenyl) glycine, valine hydantoin, sodium phenoxy acetate, phenoxy acetic acid, phenyl ac...

• Industry: Chemicals and Allied Products
• Founded: 2021
• Employees: 529
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: DSFCL